Miss anything last week?
The most-discussed and most popular article on the week was our de-tease of David Gardner's latest growth pick for the Motley Fool that he says is pushing the cancer industry into the future... my take on that story (and the Thinkolator's answer) is right here.
A promise of growth always gets our attention, so early in the week we looked at a tease for 40% growth from Mike Cintolo at Cabot... what was the "one to buy if you're buying only one" that he touted? Answers and some blatheration from yours truly if you'll just click here.
Then we turned to the Middle Kingdom, with a teaser pitch promoting Brian Tycango's newer Strategic Wealth Confidential letter from Stansberry Pacific -- Tycango says this new opportunity should eclipse the Bitcon boom by a factor of 80 as his secret stock posts huge gains on the back of Chinese infrastructure investment... so what is it? I fed the clues to the Mighty, Mighty Thinkolator, as usual, andyour answer is here.
We then turned to Jeff Siegel's Green Chip Stocks, which was tesasing us about an anti-aging drugmaker that was about to change the world -- he touted that "March 29th, 2019 will be the most profitable day in the history of mankind,â and that, of course, didn't turn out to be true... but it's still an interesting story,click here for the details.
And then, as usual, I closed up the week with our Friday File for the Irregulars -- I have a few small portfolio moves on the week, but mostly spent some time musing about "what the Fed wants us to buy." You can click below if you missed that one in your email...
